VYNE up 10% .2801

Vyne up 10%

VYNE loading zone up 6%

Something brewing at VYNE ... two weeks of sideways movement could someone be loading for a pump

VYNE up 6% again today

Vyne up 5% today. I hope this is botttom and keeps climbing.

What do you think of VYNE ? Up12% today. Is this bottom? I added some

I added a some. could this be bottom? hope so up 10% today

Time to buy? what do you think? or this setting up for another drop?

Bottom?

Good news for now No reverse split.


https://www.sec.gov/ix?doc=/Archives/edgar/data/1566044/000110465922088684/tm2222986d1_8k.htm

News out Green premarket

will this ever turn around? ...

DEFA14A out

https://quantisnow.com/insight/3119878

8K out

https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001566044&owner=include&count=40&hidefilings=0

More News


10:41 am ET


VYNE Therapeutics Concludes Patient Enrolment in Mid-Stage Study Of Skin Inflammation Candidate

VYNE Therapeutics Inc. (NASDAQ: VYNE) has concluded patient enrollment in the Phase 2a study of of its drug candidate FMX114 for the treatment of mild-to-moderate atopic dermatitis (AD).

FMX 114 is evaluated in the Phase 2a four weeks segment study for the treatment in patients suffering from atopic dermatitis compared to vehicle control.

The Phase 2a study was designed to enroll up to 25 subjects, with each subject serving as their own control.

David Domzalski, Chief Executive Officer, commented : “We have been encouraged by the early efficacy results from the Phase 1b segment of the FMX114 trial showing that, based on ADSI scoring, two weeks of FMX114 treatment demonstrated a statistically significant improvement in the signs and symptoms of AD as well as acceptable safety and pharmacokinetics.”

The company expects to report top-line efficacy results in approximately 6 to 8 weeks.

Atopic dermatitis (AD) is a chronic, severe form of eczema that is characterized by the appearance of dry, red, and itchy skin.

VYNE Therapeutics shares are trading higher 4 percent at $0.53.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

News out.

June 17, 2022

8:00 am ET


*VYNE Therapeutics Completes Enrollment In Phase 2a Trial Of FMX114 For Treatment Of Mild-To-Moderate Atopic Dermatitis
Benzinga

can we go green another day

+13.54% up can we hold and continue to climb?

Close at .50 cents

8K https://fintel.io/doc/sec-vyne-therapeutics-inc-1566044-8k-2022-may-17-19129-2276

BlackRock accumulating again?

.40 low

ATL

up 36%

https://www.globenewswire.com/news-release/2022/04/07/2418427/0/en/VYNE-Therapeutics-Announces-Positive-Phase-1b-Efficacy-Data-for-FMX114-from-Phase-1b-2a-Trial-for-the-Treatment-of-Mild-to-Moderate-Atopic-Dermatitis.html

1 hour chart, ask looks thin can this make a run today?

+22%

some life today. up 10%

Cantor Fitzgerald Reiterates VYNE Therapeutics (VYNE) Overwight, $10 PT, Sees Company's Bromodomain and Extra-Terminal Domain Inhibitors Programs are Under appreciated


https://www.streetinsider.com/Analyst+Comments/Cantor+Fitzgerald+Reiterates+VYNE+Therapeutics+%28VYNE%29+Overwight%2C+%2410+PT%2C+Sees+Companys+Bromodomain+and+Extra-Terminal+Domain+Inhibitors+Programs+are+Underappreciated/19790311.html

H.C. Wainwright Thinks VYNE Therapeutics’ Stock is Going to Recover
TipRanks - 17 Mar



H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on VYNE Therapeutics (VYNE – Research Report) today and set a price target of $7.00. The company's shares closed last Thursday at $0...
VYNE



https://www.tipranks.com/news/blurbs/h-c-wainwright-thinks-vyne-therapeutics-stock-is-going-to-recover-2?utm_source=stck.pro&utm_medium=referral

H.C. Wainwright Thinks VYNE Therapeutics’ Stock is Going to Recover
TipRanks - 17 Mar



H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on VYNE Therapeutics (VYNE – Research Report) today and set a price target of $7.00. The company's shares closed last Thursday at $0...
VYNE



https://www.tipranks.com/news/blurbs/h-c-wainwright-thinks-vyne-therapeutics-stock-is-going-to-recover-2?utm_source=stck.pro&utm_medium=referral

8K out

Perceptive advisers buying again? Lets see what Joseph Edelman is up to.

hope you correct!
Looks like this will need time to brew before it moves up.

yup

Nice climb this week ... hopefully it continues. GLTU

30mil in volume Something is up. not sure what.

maybe shorts are covering, tutes are buying , ...etc..

GLTU

up +32%

up 24%